|
|
Position:
Director of Formulation Development
Employer:
TLL Pharma, High Impact Medicines for All.
Description:
Director of Formulation Development
- The Director of Formulation will oversee small molecule development (Oral Solids, Tablets, Capsules) with a preference for Extended/Modified Release. Any experience with Sterile Dosage Forms will be a plus.
- The Director of Formulation will focus on early-stage development (Lab Scale) as well as helping to determine the best process for Scale-Up. Additionally, they will be responsible for assessing the capabilities of third party CROs/CDMOs.
- Provide leadership to Scientists when appropriate
- Direct formulation team to design and perform laboratory experiments leading to acceptable product formulation and processes
- Perform literature and patent search to support strategies and studies for development of company pipeline products
- Assist with various stages of product development, including pre-formulation, formulation development, process development, optimization, scale-up studies/technology transfer with CROs/CDMOs
- Generate data/development reports for each stage of the product development
- Support regulatory submissions
- Collaborate with other functional groups (Analytical, QC, QA, Clinical, Regulatory, Production) to advance the development of Company pipeline products
Qualifications/Experience:
Qualifications
- The qualified candidate will have a Ph.D. or M.S in Chemistry with 10+ years of experience working for pharmaceutical companies to develop and improve formulations that are delivered as small molecule oral solid/liquid dosage as well as sterile dosage forms.
- The person must also be familiar with scale-up techniques used to produce larger quantities without compromising quality.
- Hands on experience in R&D of small molecule formulations in a cGMP environment
- Solid knowledge and training on cGMP & GLP regulations
- Excellent communication skills (Written and verbal)
- Ability to perform and bring out the best in others on a cross-functional global team
- Ability to interact externally and internally to support a global scientific and business strategy
Location:
USA or China
Contact:
If interested, please send your resume to info@TLLpharma.com
Post Date:
8/4/2021 10:38:24 AM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Submit a Text Ad
|